{"disease":{"id":"dry-age-related-macular-degeneration","name":"dry age related macular degeneration"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02686658","title":"Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":286,"lead_sponsor_name":"IVERIC bio, Inc.","has_results":true},{"nct_id":"NCT04566445","title":"HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":255,"lead_sponsor_name":"Gyroscope Therapeutics Limited","has_results":true},{"nct_id":"NCT05797896","title":"Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Complement Therapeutics","has_results":false},{"nct_id":"NCT05536752","title":"QA102 Phase II Study in Subjects With Dry AMD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Smilebiotek Zhuhai Limited","has_results":false},{"nct_id":"NCT05763940","title":"Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":130,"lead_sponsor_name":"Western University of Health Sciences","has_results":false},{"nct_id":"NCT06860555","title":"Hyperspectral Drusen Classification","phase":"","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Optina Diagnostics Inc.","has_results":false},{"nct_id":"NCT04437368","title":"EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":98,"lead_sponsor_name":"Gyroscope Therapeutics Limited","has_results":true},{"nct_id":"NCT04065490","title":"Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":96,"lead_sponsor_name":"LumiThera, Inc.","has_results":false},{"nct_id":"NCT05447650","title":"Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT)","phase":"NA","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"i-Lumen Scientific, Inc.","has_results":false},{"nct_id":"NCT03894020","title":"GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)","phase":"","overall_status":"TERMINATED","enrollment_count":83,"lead_sponsor_name":"Gyroscope Therapeutics Limited","has_results":false},{"nct_id":"NCT06229665","title":"Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":75,"lead_sponsor_name":"LumiThera, Inc.","has_results":false},{"nct_id":"NCT04643886","title":"A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":62,"lead_sponsor_name":"Gemini Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03846193","title":"FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":56,"lead_sponsor_name":"Gyroscope Therapeutics Limited","has_results":true},{"nct_id":"NCT00950638","title":"A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Ophthotech Corporation","has_results":false},{"nct_id":"NCT03878420","title":"Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE II)","phase":"NA","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"LumiThera, Inc.","has_results":false},{"nct_id":"NCT06174181","title":"Preventive TREatment of Dry Eye in Patients Receiving Repeated Intravitreal Injections for Age-related Macular Degeneration","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Direction Centrale du Service de Santé des Armées","has_results":false},{"nct_id":"NCT03626636","title":"A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Allegro Ophthalmics, LLC","has_results":false},{"nct_id":"NCT06536062","title":"Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma.","phase":"NA","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05706896","title":"Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma","phase":"NA","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05259371","title":"Study of Application of Transcutaneous Pulsed Electrical Stimulation Around Eye in Age-related Macular Degeneration","phase":"NA","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Nu Eyne Co., Ltd.","has_results":false},{"nct_id":"NCT04636853","title":"CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degeneration","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT04339764","title":"Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT04627428","title":"Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"Luxa Biotechnology, LLC","has_results":false},{"nct_id":"NCT04349254","title":"Observational Study of Vision Improvement in Late Stage Dry AMD Patients","phase":"","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Optimal Acuity Corporation","has_results":false},{"nct_id":"NCT03144999","title":"Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT05667688","title":"Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"RBP4 Pty Ltd","has_results":false},{"nct_id":"NCT06872658","title":"Study to Detect Dendritic Cell Recruitment in Human Retina","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"MindImmune Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07428798","title":"Subtenon PRP Injection for Geographic Atrophy in Dry Age-Related Macular Degeneration","phase":"NA","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Marmara University Pendik Training and Research Hospital","has_results":false},{"nct_id":"NCT01344993","title":"Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Astellas Institute for Regenerative Medicine","has_results":false},{"nct_id":"NCT04246866","title":"First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Gemini Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03333954","title":"Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration","phase":"NA","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Science Corporation","has_results":false},{"nct_id":"NCT04511936","title":"Microcurrent Stimulation for Dry Age-related Macular Degeneration","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"i-Lumen Scientific, Inc.","has_results":false},{"nct_id":"NCT04358471","title":"Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Hemera Biosciences","has_results":false}],"total":33},"guidelines":[],"source":"Drug Landscape verified database"}